Abstract
A review of Helicobacter pylori in the Middle East is presented. Prevalence studies have been performed in asymptomatic population groups from Algeria, Israel, Saudi Arabia and Turkey. These showed that the prevalence of H. pylori is similar to that of the developing countries of the world with a high level of infection in childhood (40 to 70 percent), which increases with age to 85 to 90 percent. Israel, however, has a low prevalence in children (10 percent), but there is a rapid rise in the second decade of life to 39 percent, reaching 79 percent in those over 60 years old. The prevalence rates were higher in those living in communal settlements (72 percent) than in urban dwellers (65 percent). The infection rates were higher in persons of Mediterranean and Asian origin (89 percent) compared to those of Western European/North American origin (57 percent). The prevalence rate of H. pylori infection in patients undergoing endoscopy for upper gastrointestinal symptoms has now been reported from many Middle Eastern countries, including Egypt, Iran, Israel, Oman, Saudi Arabia, the United Arab Emirates and Yemen. These studies showed that patients with gastritis and peptic ulcer disease had similar rates of infection as reported from Europe, United States and Africa (71 to 92 percent). However, patients with non-ulcer dyspepsia had higher rates of infection (61 to 89 percent). The H. pylori scenario from the prevalence rates, treatment protocols and responses to treatment does not differ very much from other developing areas of the world.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Buckley M., O'Morain C. Prevalence of Helicobacter pylori in non-ulcer dyspepsia. Aliment Pharmacol Ther. 1995;9 (Suppl 2):53–58. [PubMed] [Google Scholar]
- Cullen D. J., Collins B. J., Christiansen K. J., Epis J., Warren J. R., Surveyor I., Cullen K. J. When is Helicobacter pylori infection acquired? Gut. 1993 Dec;34(12):1681–1682. doi: 10.1136/gut.34.12.1681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dooley C. P., Cohen H., Fitzgibbons P. L., Bauer M., Appleman M. D., Perez-Perez G. I., Blaser M. J. Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med. 1989 Dec 7;321(23):1562–1566. doi: 10.1056/NEJM198912073212302. [DOI] [PubMed] [Google Scholar]
- Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut. 1993 Dec;34(12):1672–1676. doi: 10.1136/gut.34.12.1672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gabay G., Novis B. H., Pomeranz I. S., Bernheim J., Leichtmann G., Peri M., Avni A. Helicobacter pylori infection--its prevalence and diagnosis in Israel. Isr J Med Sci. 1991 Jun;27(6):335–337. [PubMed] [Google Scholar]
- Gilboa S., Gabay G., Zamir D., Zeev A., Novis B. Helicobacter pylori infection in rural settlements (Kibbutzim) in Israel. Int J Epidemiol. 1995 Feb;24(1):232–237. doi: 10.1093/ije/24.1.232. [DOI] [PubMed] [Google Scholar]
- Graham D. Y., Malaty H. M., Evans D. G., Evans D. J., Jr, Klein P. D., Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States. Effect of age, race, and socioeconomic status. Gastroenterology. 1991 Jun;100(6):1495–1501. doi: 10.1016/0016-5085(91)90644-z. [DOI] [PubMed] [Google Scholar]
- Kosunen T. U., Hök J., Rautelin H. I., Myllylä G. Age-dependent increase of Campylobacter pylori antibodies in blood donors. Scand J Gastroenterol. 1989 Jan;24(1):110–114. doi: 10.3109/00365528909092247. [DOI] [PubMed] [Google Scholar]
- Kuipers E. J., Thijs J. C., Festen H. P. The prevalence of Helicobacter pylori in peptic ulcer disease. Aliment Pharmacol Ther. 1995;9 (Suppl 2):59–69. [PubMed] [Google Scholar]
- Latif A. H., Shami S. K., Batchoun R., Murad N., Sartawi O. Helicobacter pylori: a Jordanian study. Postgrad Med J. 1991 Nov;67(793):994–998. doi: 10.1136/pgmj.67.793.994. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Louw J. A., Falck V., van Rensburg C., Zak J., Adams G., Marks I. N. Distribution of Helicobacter pylori colonisation and associated gastric inflammatory changes: difference between patients with duodenal and gastric ulcers. J Clin Pathol. 1993 Aug;46(8):754–756. doi: 10.1136/jcp.46.8.754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Massarrat S., Saberi-Firoozi M., Soleimani A., Himmelmann G. W., Hitzges M., Keshavarz H. Peptic ulcer disease, irritable bowel syndrome and constipation in two populations in Iran. Eur J Gastroenterol Hepatol. 1995 May;7(5):427–433. [PubMed] [Google Scholar]
- Morris A., Nicholson G., Lloyd G., Haines D., Rogers A., Taylor D. Seroepidemiology of Campylobacter pyloridis. N Z Med J. 1986 Sep 10;99(809):657–659. [PubMed] [Google Scholar]
- Moshkowitz M., Konikoff F. M., Arber N., Peled Y., Santo M., Bujanover Y., Gilat T. Seasonal variation in the frequency of Helicobacter pylori infection: a possible cause of the seasonal occurrence of peptic ulcer disease. Am J Gastroenterol. 1994 May;89(5):731–733. [PubMed] [Google Scholar]
- Moshkowitz M., Konikoff F. M., Peled Y., Brill S., Hallak A., Tiomny E., Santo M., Bujanover Y., Gilat T. One week triple therapy with omeprazole, clarithromycin and tinidazole for Helicobacter pylori: differing efficacy in previously treated and untreated patients. Aliment Pharmacol Ther. 1996 Dec;10(6):1015–1019. doi: 10.1046/j.1365-2036.1996.96268000.x. [DOI] [PubMed] [Google Scholar]
- Mégraud F., Brassens-Rabbé M. P., Denis F., Belbouri A., Hoa D. Q. Seroepidemiology of Campylobacter pylori infection in various populations. J Clin Microbiol. 1989 Aug;27(8):1870–1873. doi: 10.1128/jcm.27.8.1870-1873.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Perez-Perez G. I., Dworkin B. M., Chodos J. E., Blaser M. J. Campylobacter pylori antibodies in humans. Ann Intern Med. 1988 Jul 1;109(1):11–17. doi: 10.7326/0003-4819-109-1-11. [DOI] [PubMed] [Google Scholar]
- Pounder R. E., Ng D. The prevalence of Helicobacter pylori infection in different countries. Aliment Pharmacol Ther. 1995;9 (Suppl 2):33–39. [PubMed] [Google Scholar]
- Satti M. B., Twum-Danso K., al-Freihi H. M., Ibrahim E. M., al-Gindan Y., al-Quorain A., al-Ghassab G., al-Hamdan A., al-Idrissi H. Y. Helicobacter pylori-associated upper gastrointestinal disease in Saudi Arabia: a pathologic evaluation of 298 endoscopic biopsies from 201 consecutive patients. Am J Gastroenterol. 1990 May;85(5):527–534. [PubMed] [Google Scholar]
- Shousha S., el-Sherif A. M., el-Guneid A., Arnaout A. H., Murray-Lyon I. M. Helicobacter pylori and intestinal metaplasia: comparison between British and Yemeni patients. Am J Gastroenterol. 1993 Sep;88(9):1373–1376. [PubMed] [Google Scholar]
- Tytgat G. N., Noach L. A., Rauws E. A. Helicobacter pylori infection and duodenal ulcer disease. Gastroenterol Clin North Am. 1993 Mar;22(1):127–139. [PubMed] [Google Scholar]
- Zaitoun A. M. Histological study of chronic gastritis from the United Arab Emirates using the Sydney system of classification. J Clin Pathol. 1994 Sep;47(9):810–815. doi: 10.1136/jcp.47.9.810. [DOI] [PMC free article] [PubMed] [Google Scholar]
- al-Moagel M. A., Evans D. G., Abdulghani M. E., Adam E., Evans D. J., Jr, Malaty H. M., Graham D. Y. Prevalence of Helicobacter (formerly Campylobacter) pylori infection in Saudia Arabia, and comparison of those with and without upper gastrointestinal symptoms. Am J Gastroenterol. 1990 Aug;85(8):944–948. [PubMed] [Google Scholar]